CRSP
CRISPR Therapeutics AG
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
CRISPR Therapeutics (CRSP) Stock: Buy, Sell, or Hold?
$42.90
-2.85 (-6.23%)
▼
5d:
-11.66%
30d:
-14.58%
90d:
-19.89%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 09, 2026
0d
Protect CRSP Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$47.83 – $53.23
Position: OVERSOLD
Forward P/E & Valuation
-12.5x
Next 12M consensus est.
Wall Street Target
$85.42
+86.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$43.30 / $54.10
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: CRSP is down 11.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When CRSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CRSP is currently trading at $42.90, which is considered oversold relative to its 30-day fair value range of $47.83 to $53.23.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is currently testing key support at $43.30. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: CRSP scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $85.42 (+86.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is currently testing key support at $43.30. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: CRSP scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $85.42 (+86.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$47.83 -
$53.23
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$47.83 -
$53.23
Current vs Trading Range
OVERSOLD
Support Level
$43.30
Resistance Level
$54.10
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding CRSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.2%)
- BULLISH: Trading 86.7% below Wall St target ($85.42)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-12.46
Wall Street Target
$85.42
(+86.7%)
Revenue Growth (YoY)
1325.1%
Share CRSP Analysis
Share this live CRSP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CRSP)
Bearish
3 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
CRISPR Therapeutics (CRSP) announced that members of its senior management team will present at the 2026 Jefferies Global Healthcare Conference. The Company is a leading biopharmaceutical company focused on developing transformative gene-based medicines for serious human diseases.
Key Retail Themes:
Company's focus on developing transformative gene-based medicines
Upcoming presentation at the Jefferies Global Healthcare Conference
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:00 PM ET
Data refreshes hourly during market hours. Next update: 3:00 PM
Data refreshes hourly during market hours. Next update: 3:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 58 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Advanced CRSP Option Strategies
Professional options setups generated by AI based on today's CRSP price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CRSP Research Pages
